Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000011512
JPRN-UMIN000011512
Completed
未知

The clinical study for the effect of oral supplementary drugs containing lutein on macular pigment density - The effect of oral supplementary drug containing lutein on macular pigment density

The department of Ophthalmology, School of medicine, The university of tokyo0 sites40 target enrollmentAugust 29, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsThe patients with early age-related macular degeneration and healthy volunteer participants

Overview

Phase
未知
Intervention
Not specified
Conditions
The patients with early age-related macular degeneration and healthy volunteer participants
Sponsor
The department of Ophthalmology, School of medicine, The university of tokyo
Enrollment
40
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 29, 2013
End Date
August 20, 2014
Last Updated
2 years ago
Study Type
Interventional,observational
Sex
All

Investigators

Sponsor
The department of Ophthalmology, School of medicine, The university of tokyo

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •patients with early age\-related macular degeneration: patients with cataract which could prevent clear fundus autofluorescent image. patients with some kinds of systemic disease which could cause macular abnormality. healthy volunteer participants: who is affected with some kinds of dieases which could cause macular abnormalities, pregnant, possibly pregnant.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study for evaluating the effect of oral supplementation using gamma-aminobutyric acid (GABA) and whey protein on muscle hypertrophy in meHealthy men
JPRN-UMIN000025842Pharma Foods International Co., Ltd.26
Recruiting
Phase 2
Role of an Ayurvedic Formulation in Management of Vitiligo in ChildreHealth Condition 1: L80- Vitiligo
CTRI/2020/03/024214ayan Kumar S
Completed
Early Phase 1
effect of supplement containing Astaxanthin and alpha linolenic acid in coronary artery stenosis
IRCT2016050327727N1Vice chancellor for research, Ahvaz Jundishapour University of Medical Sciences44
Completed
Not Applicable
Analysis of the effect of oral nutritional supplement or branched chain amino acid (BCAA) on liver cirrhotic patients with less than 3.5 g/dl of serum albumin level.
JPRN-UMIN000011183Kanazawa Medical University40
Completed
Not Applicable
The effects of oral administration of bulleyaconitine A in postherpetic neuralgia
ISRCTN16975505Xinhua Hospital affiliated with Shanghai Jiaotong University School of Medicine120